CoChat
Sign Up
Cited by 77

The DOI matches its Crossref record.

Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting

Harris, Magdalena, Rhodes, Tim, Martin, Anthea·2013·Social Science & Medicine
DOI 10.1016/j.socscimed.2013.01.031
Open this paper in CoChat — free account

Abstract

HCV (hepatitis C) treatment uptake among the population most affected - people who inject drugs - is suboptimal. Hospital based treatment provision is one evidenced barrier to HCV treatment uptake. In response, HCV treatment is increasingly located in treatment settings seen as more amenable to people who inject drugs, such as drug and alcohol services. We explored the accessibility of HCV treatment provision at two such partnerships. Data collection comprised qualitative interviews collected in 2011 and 2012 with 35 service users and 14 service providers of HCV treatment in London, United Kingdom. We draw here primarily on thematic analyses of service provider accounts, yet narratives relating to trust and environment emerged unsolicited in both user and provider accounts of negotiated HCV treatment access. A key theme in service provider accounts were strategies they deployed to 'tame' the treatment system so as to create an 'enabling environment' of care, in which trust was a critical feature. This 'taming' of the system was enacted through practices of 'negotiated flexibility', including in relation to appointments, eligibility, and phlebotomy. Service user accounts accentuated familiar environments and known health providers as those most trusted, and the potentially stigmatising effects of negotiating treatment in unfamiliar territory, especially hospital settings. Whilst noting the effects of provider strategies to negotiate flexibility on behalf of would-be patients s…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.socscimed.2013.01.031

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. Barbour, 2011, The biographical turn and the ‘socialization’ of medicine, Medical Sociology Online, 6, 15
  2. Canfield, 2010, Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for HCV infection, Substance Use & Misuse, 45, 496, 10.3109/10826080903452538 · DOI
  3. Carr, 2001, Negotiating trust: a grounded theory study of interpersonal relationships between persons living with HIV/AIDS and their primary health care providers, Journal of the Association of Nurses in AIDS Care, 12, 35, 10.1016/S1055-3290(06)60132-5 · DOI
  4. Davies, 1999, Falling public trust in health services: Implications for accountability, Journal of Health Services Research & Policy, 4, 193, 10.1177/135581969900400401 · DOI
  5. Ghany, 2009, Diagnosis, management and treatment of HCV: an update, Hepatology, 49, 1335, 10.1002/hep.22759 · DOI
  6. Gilson, 2003, Trust and the development of health care as a social institution, Social Science & Medicine, 56, 1453, 10.1016/S0277-9536(02)00142-9 · DOI
  7. Harris, 2012, Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs, Addiction, 107, 1090, 10.1111/j.1360-0443.2011.03749.x · DOI
  8. Harris, 2012, Methadone diversion as a protective strategy: the harm reduction potential of ‘generous constraints’, International Journal of Drug Policy
  9. Harris, M. & Rhodes, T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduction Journal, submitted for publication.
  10. Jauffret-Roustide, 2012, Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician, AIDS Care, 24, 232, 10.1080/09540121.2011.596515 · DOI
  11. Kirst, 2009, Social capital and beyond, Journal of Drug Issues, 39, 653, 10.1177/002204260903900309 · DOI
  12. Lally, 2008, A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV, AIDS Patient Care & STDs, 22, 53, 10.1089/apc.2006.0206 · DOI
  13. Lazarus, 2007, HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management, International Journal of Drug Policy, 18, 426, 10.1016/j.drugpo.2007.01.011 · DOI
  14. Ly, 2012, The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007, Annals of Internal Medicine, 156, 271, 10.7326/0003-4819-156-4-201202210-00004 · DOI
  15. Martin, 2011, Can antiviral therapy for HCV reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility, Journal of Hepatology, 54, 1137, 10.1016/j.jhep.2010.08.029 · DOI
  16. Neale, 2008, Homelessness, drug use and hepatitis C: a complex problem explored within the context of social exclusion, International Journal of Drug Policy, 19, 429, 10.1016/j.drugpo.2007.09.001 · DOI
  17. Osilla, 2009, Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment, AIDS Patient Care and STDs, 23, 993, 10.1089/apc.2009.0153 · DOI
  18. Ostertag, 2006, Trust and other characteristics associated with health care utilization by injection drug users, Journal of Drug Issues, 36, 953, 10.1177/002204260603600409 · DOI
  19. Palmateer, 2010, Evidence for the effectiveness of sterile injecting equipment provision in preventing HCV and HIV transmission among injecting drug users: a review of reviews, Addiction, 105, 844, 10.1111/j.1360-0443.2009.02888.x · DOI
  20. Paterson, 2007, The depiction of stigmatization in research about hepatitis C, International Journal of Drug Policy, 18, 364, 10.1016/j.drugpo.2007.02.004 · DOI
  21. Rance, 2012, The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics, Social Science & Medicine, 74, 245, 10.1016/j.socscimed.2011.10.003 · DOI
  22. Rhodes, 2013, Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment, Sociology of Health and Illness, 10.1111/1467-9566.12018 · DOI
  23. Rhodes, 2008, Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk, Health, Risk & Society, 10, 221, 10.1080/13698570802160921 · DOI
  24. Swan, 2010, Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration, AIDS Patient Care & STDs, 24, 753, 10.1089/apc.2010.0142 · DOI
  25. Thom, 1997, Patient-physician trust: an exploratory study, The Journal of Family Practice, 44, 169
  26. Treloar, 2009, Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view, Drug and Alcohol Review, 28, 436, 10.1111/j.1465-3362.2009.00031.x · DOI
  27. Treloar, 2008, Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings, Australian Health Review, 32, 570, 10.1071/AH080570 · DOI
  28. Treloar, 2010, Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals, Journal of Viral Hepatitis, 17, 839, 10.1111/j.1365-2893.2009.01250.x · DOI

Cited by

Sorted by citations

See all 77

Metadata

Authors
Harris, M., Rhodes, T., & Martin, A.
Venue
Social Science & Medicine
Publisher
Elsevier BV
Published
2013-04
Volume
83
Pages
19-26
ISSN
0277-9536
DOI
10.1016/j.socscimed.2013.01.031
Cited by
77
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
WHO Regional Office for Europe

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting. https://app.cochat.ai/papers/10.1016/j.socscimed.2013.01.031
The paper
Harris, M., Rhodes, T., & Martin, A. (2013). Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting. Social Science & Medicine. https://doi.org/10.1016/j.socscimed.2013.01.031